EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Influenza A virus strain PR/8/34, but neither HAM/2009 nor WSN/33, is transiently inhibited by the PB2-targeting drug paliperidone

Georgios-Dimitrios Panagiotidis, Christin Müller, Marco Binder, Friedemann Weber

Archives of Virology · 2023

DOI: 10.1007/s00705-022-05696-0 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archives of Virology, 2023. Verfasst von Georgios-Dimitrios Panagiotidis und 3 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Virology, FB10-Veterinary Medicine, Justus-Liebig University, 35392, Giessen, Germany. Hauptthemen laut MEDLINE: Influenza A virus, Paliperidone Palmitate, Antiviral Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft, Deutsches Zentrum für Infektionsforschung, Justus-Liebig-Universität Gießen.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Influenza A virus (FLUAV) is a significant human pathogen. In silico structural analysis (PMID 28628827) has suggested that the FDA-approved drug paliperidone interferes with the binding of the FLUAV polymerase subunit PB2 to the nucleoprotein NP. We found that paliperidone inhibits FLUAV A/PR/8/34 early after infection of canine MDCK II, human A549, and human primary bronchial cells, but not at late time points. No effect was detectable against the strains A/Hamburg/05/2009 and A/WSN/33. Moreover, paliperidone indeed disturbed the interaction between the PB2 and the NP of A/PR/8/34 and reduced early viral RNA and protein synthesis by approximately 50%. Thus, paliperidone has measurable but transient and virus-strain-restricted effects on FLUAV.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Influenza A virusPaliperidone PalmitateAntiviral AgentsAnimalsDogsHumansNucleoproteinsRNA, ViralViral ProteinsVirus ReplicationMadin Darby Canine Kidney CellsA549 Cells

Substanzen

NucleoproteinsPaliperidone PalmitateRNA, ViralViral ProteinsAntiviral Agents

Autor:innen und Institutionen

  • Institute for Virology, FB10-Veterinary Medicine, Justus-Liebig University, 35392, Giessen, Germany.
  • Institute for Medical Virology, FB11-Medicine, Justus-Liebig University, 35392, Giessen, Germany.
  • German Center for Infection Research (DZIF), Partner Site Giessen, Germany.
  • Research Group "Dynamics of early viral infection and the innate antiviral response", Division "Virus-Associated Carcinogenesis", German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Institute for Virology, FB10-Veterinary Medicine, Justus-Liebig University, 35392, Giessen, Germany. friedemann.weber@vetmed.uni-giessen.de.
  • German Center for Infection Research (DZIF), Partner Site Giessen, Germany. friedemann.weber@vetmed.uni-giessen.de.

Förderung

  • Deutsche Forschungsgemeinschaft
  • Deutsches Zentrum für Infektionsforschung
  • Justus-Liebig-Universität Gießen

Zitieren

APA

Panagiotidis, G. D., Müller, C., Binder, M., & Weber, F. (2023). Influenza A virus strain PR/8/34, but neither HAM/2009 nor WSN/33, is transiently inhibited by the PB2-targeting drug paliperidone. Archives of Virology. https://doi.org/10.1007/s00705-022-05696-0

Vancouver

Panagiotidis GD, Müller C, Binder M, Weber F. Influenza A virus strain PR/8/34, but neither HAM/2009 nor WSN/33, is transiently inhibited by the PB2-targeting drug paliperidone. Archives of Virology. 2023. doi:10.1007/s00705-022-05696-0

BibTeX
@article{Panagiotidis2023,
  author = {Panagiotidis, Georgios-Dimitrios and Müller, Christin and Binder, Marco and Weber, Friedemann},
  title = {Influenza A virus strain PR/8/34, but neither HAM/2009 nor WSN/33, is transiently inhibited by the PB2-targeting drug paliperidone},
  journal = {Archives of Virology},
  year = {2023},
  doi = {10.1007/s00705-022-05696-0}
}
Kostenlos starten →